Stem cell technology for neurodegenerative diseases JS Lunn, SA Sakowski, J Hur, EL Feldman Annals of neurology 70 (3), 353-361, 2011 | 328 | 2011 |
Amyotrophic lateral sclerosis: mechanisms and therapeutics in the epigenomic era X Paez-Colasante, C Figueroa-Romero, SA Sakowski, SA Goutman, ... Nature Reviews Neurology 11 (5), 266-279, 2015 | 247 | 2015 |
Mouse models of diabetic neuropathy PD O'Brien, SA Sakowski, EL Feldman ILAR journal 54 (3), 259-272, 2014 | 240 | 2014 |
Intraspinal neural stem cell transplantation in amyotrophic lateral sclerosis: phase 1 trial outcomes EL Feldman, NM Boulis, J Hur, K Johe, SB Rutkove, T Federici, M Polak, ... Annals of neurology 75 (3), 363-373, 2014 | 224 | 2014 |
Perspective: transforming science into medicine: how clinician–scientists can build bridges across research's “valley of death” SF Roberts, MA Fischhoff, SA Sakowski, EL Feldman Academic Medicine 87 (3), 266-270, 2012 | 191 | 2012 |
Differential tissue distribution of tryptophan hydroxylase isoforms 1 and 2 as revealed with monospecific antibodies SA Sakowski, TJ Geddes, DM Thomas, E Levi, JS Hatfield, DM Kuhn Brain research 1085 (1), 11-18, 2006 | 172 | 2006 |
ER stress in diabetic peripheral neuropathy: a new therapeutic target PD O'Brien, LM Hinder, SA Sakowski, EL Feldman Antioxidants & redox signaling 21 (4), 621-633, 2014 | 107 | 2014 |
Vascular endothelial growth factor prevents G93A‐SOD1‐induced motor neuron degeneration JS Lunn, SA Sakowski, B Kim, AA Rosenberg, EL Feldman Developmental neurobiology 69 (13), 871-884, 2009 | 102 | 2009 |
Expression of microRNAs in human post-mortem amyotrophic lateral sclerosis spinal cords provides insight into disease mechanisms C Figueroa-Romero, J Hur, JS Lunn, X Paez-Colasante, DE Bender, ... Molecular and Cellular Neuroscience 71, 34-45, 2016 | 99 | 2016 |
Concise review: Stem cell therapies for amyotrophic lateral sclerosis: recent advances and prospects for the future JS Lunn, SA Sakowski, EL Feldman Stem cells 32 (5), 1099-1109, 2014 | 93 | 2014 |
Translational stem cell therapy for amyotrophic lateral sclerosis NM Boulis, T Federici, JD Glass, JS Lunn, SA Sakowski, EL Feldman Nature Reviews Neurology 8 (3), 172-176, 2012 | 93 | 2012 |
BTBR ob/ob mice as a novel diabetic neuropathy model: Neurological characterization and gene expression analyses PD O'Brien, J Hur, JM Hayes, C Backus, SA Sakowski, EL Feldman Neurobiology of disease 73, 348-355, 2015 | 91 | 2015 |
Nitrotyrosine as a marker for peroxynitrite‐induced neurotoxicity: the beginning or the end of the end of dopamine neurons? DM Kuhn, SA Sakowski, M Sadidi, TJ Geddes Journal of neurochemistry 89 (3), 529-536, 2004 | 86 | 2004 |
Neuromuscular effects of G93A-SOD1 expression in zebrafish SA Sakowski, JS Lunn, AS Busta, SS Oh, G Zamora-Berridi, M Palmer, ... Molecular neurodegeneration 7, 1-15, 2012 | 85 | 2012 |
Stem cell technology for the study and treatment of motor neuron diseases JS Lunn, SA Sakowski, T Federici, JD Glass, NM Boulis, EL Feldman Regenerative medicine 6 (2), 201-213, 2011 | 84 | 2011 |
Human cortical neural stem cells expressing insulin-like growth factor-I: a novel cellular therapy for Alzheimer's disease LM McGinley, E Sims, JS Lunn, ON Kashlan, KS Chen, ES Bruno, ... Stem cells translational medicine 5 (3), 379-391, 2016 | 80 | 2016 |
Insulin-like growth factor-I for the treatment of amyotrophic lateral sclerosis SA Sakowski, AD Schuyler, EL Feldman Amyotrophic Lateral Sclerosis 10 (2), 63-73, 2009 | 79 | 2009 |
Stem cell treatments for amyotrophic lateral sclerosis: a critical overview of early phase trials SA Goutman, MG Savelieff, SA Sakowski, EL Feldman Expert opinion on investigational drugs 28 (6), 525-543, 2019 | 61 | 2019 |
Neuroprotection using gene therapy to induce vascular endothelial growth factor-A expression SA Sakowski, SB Heavener, JS Lunn, K Fung, SS Oh, SK Spratt, ... Gene therapy 16 (11), 1292-1299, 2009 | 51 | 2009 |
Long‐term phase 1/2 intraspinal stem cell transplantation outcomes in ALS SA Goutman, MB Brown, JD Glass, NM Boulis, K Johe, T Hazel, ... Annals of clinical and translational neurology 5 (6), 730-740, 2018 | 48 | 2018 |